# VELSIPITY
> **NDA216956** · New Drug Application · Sponsor: PFIZER · Approved 2023-10-12
## Drug
- **FDA Application Number:** NDA216956
- **Application type:** New Drug Application
- **Brand name:** VELSIPITY
- **Generic name:** ETRASIMOD
- **Active ingredients:** ETRASIMOD ARGININE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2023-10-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216956)
---
*AI Analytics · CC0 1.0*